| Literature DB >> 28972591 |
T Winton-Brown1,2, A Schmidt1, J P Roiser3, O D Howes1,4, A Egerton1, P Fusar-Poli5,6, N Bunzeck7,8, A A Grace9, E Duzel3, S Kapur1,10, P McGuire1.
Abstract
Animal models of psychosis propose that abnormal hippocampal activity drives increased subcortical dopamine function, which is thought to contribute to aberrant salience processing and psychotic symptoms. These effects appear to be mediated through connections between the hippocampus, ventral striatum/pallidum and the midbrain. The aim of the present study was to examine the activity and connectivity in this pathway in people at ultra high risk (UHR) for psychosis. Functional magnetic resonance imaging was used to compare neural responses in a hippocampal-basal ganglia-midbrain network during reward, novelty and aversion processing between 29 UHR subjects and 32 healthy controls. We then investigated whether effective connectivity within this network is perturbed in UHR subjects, using dynamic causal modelling (DCM). Finally, we examined the relationship between alterations in activation and connectivity in the UHR subjects and the severity of their psychotic symptoms. During reward anticipation, UHR subjects showed greater activation than controls in the ventral pallidum bilaterally. There were no differences in activation during novelty or aversion processing. DCM revealed that reward-induced modulation of connectivity from the ventral striatum/pallidum to the midbrain was greater in UHR subjects than controls, and that in UHR subjects, the strength of connectivity in this pathway was correlated with the severity of their abnormal beliefs. In conclusion, ventral striatal/pallidal function is altered in people at UHR for psychosis and this is related to the level of their psychotic symptoms.Entities:
Mesh:
Year: 2017 PMID: 28972591 PMCID: PMC5682600 DOI: 10.1038/tp.2017.174
Source DB: PubMed Journal: Transl Psychiatry ISSN: 2158-3188 Impact factor: 6.222
Demographic and clinical characteristics of the study sample
| Age (mean±s.d.) | 23.69±4.08 | 21.17±3.08 | |
| Gender (F/M) | 14/18 | 16/13 | |
| Handedness (R/L) | 28/4 | 25/4 | |
| Years of education (mean±s.d.) | 14.06±2.27 | 12.51±1.92 | |
| Smoker (yes/no) | 8/24 | 13/16 | |
| Reported previous use of illicit psychoactive substances (yes/no) | 19/10 | 19/13 | |
| Reported ongoing occasional cannabis use (yes/no) | 5/27 | 5/24 | |
| Premorbid IQ (NART, mean±s.d.) | 110±9.5 | 114±11.4 | |
| GAF (mean±s.d.) | 81.91±10.7 | 54.57± 6.75 | |
| CAARMS positive (mean±s.d.) | — | 8.07±3.49 | — |
| CAARMS negative (mean±s.d.) | — | 7.04±2.82 | — |
| PANSS positive (mean±s.d.) | — | 12.8±3.95 | — |
| PANSS negative (mean±s.d.) | — | 14.40±4.17 | — |
Abbreviations: CAARMS, Comprehensive Assessment of AT Risk Mental States; CAARMS positive symptoms were the sum of severity scores for unusual thought content, non-bizarre ideas, perceptual abnormalities and disorganized speed; CAARMS negative symptoms were the sum of severity scores for alogia, avolition/apathy and anhedonia; GAF, global assessment of function; NART, National Adult reading test; PANSS, Positive and Negative Syndrome Scale; s.d., standard deviation.
Figure 1Salience Intigration Task effects in healthy control subjects. Reward predicting stimuli-related activation was seen in the midbrain, bilateral orbitofrontal cortices and visual areas. Novel stimuli-related activation was seen in the hippocampus and secondary visual cortices bilaterally. Aversive stimuli-related activation was seen in the amygdala, hippocampus and midbrain bilaterally, visual and fusiform cortices, and orbital, ventromedial and dorsolateral prefrontal cortices.
Figure 2Ultra high-risk (UHR) subjects showed greater activation than healthy controls (HCs) in relation to reward-predicting stimuli in the ventral pallidum bilaterally and in the left midbrain/hippocampus. Images are displayed at a cluster-forming threshold of P<0.005.
Group differences in fMRI task main effects
| P- | P- | T- | ||||||
|---|---|---|---|---|---|---|---|---|
| Reward | UHR>HC | 57 | 0.015 | 0.045 | 3.96 | 3.71 | −21, −13, −8 | L Ventral Pallidum |
| 11 | 0.034 | 0.12 | 3.67 | 3.46 | 18, −7, −5 | R Ventral Pallidum | ||
| 10 | 0.013 | 0.039 | 3.44 | 3.27 | −15, −16, −11 | L Midbrain | ||
| 24 | 0.081 | 0.243 | 3.48 | 3.30 | −21, −31, −5 | L Hippocampus (subic) | ||
| UHR<HC | NIL | |||||||
| Novelty | UHR>HC | NIL | ||||||
| UHR<HC | NIL | |||||||
| Aversion | UHR>HC | NIL | ||||||
| UHR<HC | NIL |
Abbreviations: FWEroi, family-wise error corrected within individual regions of interest; FWEroi-bc, family-wise error corrected within Bonferroni-corrected regions of interest; HC, healthy controls; MNI, Montreal Neurological Institute; UHR, ultra high risk.
Figure 3(a) Increased reward-induced modulation of ventral striatum/pallidum to midbrain connectivity in ultra high-risk individuals relative to healthy controls. (b) Positive correlation between reward-induced modulation of ventral striatum/pallidum to midbrain connectivity and abnormal beliefs (CAARMS ‘Unusual Thought Content’ item, severity × frequency) in ultra high risk subjects (r=0.499, P=0.009).